PMGC HOLDINGS INC. Payments to Acquire Other Productive Assets
PMGC HOLDINGS INC. (ELAB) reported Payments to Acquire Other Productive Assets of $11.19 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2024-03-29
- PMGC HOLDINGS INC. payments to acquire other productive assets for the quarter ending 2023-12-31 was -$11.18M.
- PMGC HOLDINGS INC. payments to acquire other productive assets for the quarter ending 2022-12-31 was -$36.89M.
- PMGC HOLDINGS INC. payments to acquire other productive assets for fiscal 2023 was $11.19K, a 68.50% decline from fiscal 2022.
- PMGC HOLDINGS INC. payments to acquire other productive assets for fiscal 2022 was $35.53K.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 9 month | Payments to Acquire Other Productive Assets 12 month |
|---|---|---|---|
| 2023-12-31 | -$11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $11.19K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $11.19M 10-Q · filed 2023-12-11 | ||
| 2022-12-31 | -$36.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $35.53K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $36.93M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |